Degree of nephrotoxicity after intermediate or high-dose cisplatin-based chemoradiotherapy (CRT) in patients with locally advanced head and neck cancer (LAHNC).

被引:0
作者
Driessen, Chantal
Uijen, Maike
Van der Graaf, Winette T. A.
Kaanders, J. H.
Nijenhuis, Tom
Van Herpen, Carla M. L.
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6525 ED Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands
关键词
D O I
10.1200/jco.2014.32.15_suppl.6056
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6056
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer
    Driessen, Chantal M. L.
    Uijen, Maike J. M.
    van der Graaf, Winette T. A.
    van Opstal, Claudia C. M.
    Kaanders, Johannes H. A. M.
    Nijenhuis, Tom
    van Herpen, Carla M. L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E1575 - E1581
  • [2] Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy
    Driessen, Chantal M. L.
    Leijendeckers, Joop
    Snik, Ad
    van der Graaf, Winette T. A.
    de Boer, Jan Paiul
    Gelderblom, Hans
    Kaanders, Johannes H. A. M.
    Takes, Robert
    van Herpen, Carla M. L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (02): : 488 - 494
  • [3] Ototoxicity in locally advanced head and neck cancer (LAHNC) patients (pts) treated with induction chemotherapy (IC) followed by cisplatin-based chemoradiotherapy (CRT)
    Driessen, C.
    Snik, A.
    Leijendeckers, J.
    de Boer, J. P.
    Gelderblom, H.
    van Opstal, C.
    van der Graaf, W.
    Kaanders, J.
    van Herpen, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas
    Hoek, Jantien
    Bloemendal, Karen M.
    van der Velden, Lilly-Ann A.
    van Diessen, Judi N. A.
    van Werkhoven, Erik
    Klop, Willem M. C.
    Tesselaar, Margot E. T.
    CANCERS, 2016, 8 (02):
  • [5] NEPHROTOXICITY IN PATIENTS WITH HEAD-AND-NECK CANCER TREATED WITH HIGH-DOSE CISPLATIN
    Khaing, M.
    Dzienis, M. R.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 57 - 57
  • [6] Prophylactic antibiotics to prevent pneumonia in patients treated with chemoradiotherapy (CRT) for locally advanced head and neck carcinoma (LAHNC).
    Ham, Janneke
    Driessen, Chantal
    Hendriks, Mathijs P.
    Fiets, W. Edward
    Kreike, Bas
    Hoeben, Ann
    Slingerland, Marije
    van Opstal, Claudia
    Kullberg, Bart-Jan
    Peer, Petronella
    Kaanders, Johannes
    van der Graaf, Winette T. A.
    Van Herpen, Carla M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Chemoradiotherapy with high-dose cisplatin compared with weekly cisplatin for locally advanced head and neck squamous cell carcinoma
    Hughes, Ryan T.
    Porosnicu, Mercedes
    Levine, Beverly J.
    Lycan, Thomas W., Jr.
    Shenker, Rachel F.
    Frizzell, Bart A.
    Greven, Kathryn M.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2021, 65 (06) : 796 - 805
  • [8] Genetic variants as predictive markers for ototoxicity and nephrotoxicity in patients (pts) with locally advanced head and neck cancer (LAHNC) treated with cisplatin-containing chemoradiotherapy (ccCRT).
    Driessen, Chantal
    Ham, Janneke
    Maroeska, Dunja
    Loo, W. M. Te
    Van Meerten, Esther
    Takes, Robert P.
    Van der Graaf, Winette T. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment
    Hu, Ming-Hung
    Wang, Ling-Wei
    Lu, Hsueh-Ju
    Chu, Pen-Yuan
    Tai, Shyh-Kuan
    Lee, Tsung-Lun
    Chen, Ming-Huang
    Yang, Muh-Hwa
    Chang, Peter Mu-Hsin
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [10] Quality of life of patients with locally advanced head and neck cancer (LAHNC) treated with docetaxel/cisplatin/5-fluorouracil (TPF) followed by cisplatin-containing chemoradiotherapy (CRT).
    Driessen, Chantal
    Groenewoud, Hans
    De Boer, J. P.
    Gelderblom, Hans
    Tesselaar, Margot Et
    Van der Graaf, Winette T. A.
    Kaanders, J. H.
    L-Van Herpen, Carla M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)